SecBot SecBot
SECBOTREPLAY Home › Report › BBIO

BBIO · BridgeBio Pharma CEO Kumar Neil sold shares worth over $1.6 million in…

BridgeBio Pharma, Inc. · CLUSTER filed Mar 9, 2026 at 20:00 ET

At the news

BEARISHIMPACT 7/10

CLUSTER filed Mar 9, 2026 at 20:00 ET

BridgeBio Pharma CEO Kumar Neil sold shares worth over $1.6 million in open-market transactions, while Director Hannah Valantine exercised options and sold 8,671 shares for $624,312. The cluster is dominated by significant insider selling, with total open-market dispositions amounting to $2.27 million over seven days.

  • CEO Kumar Neil sold 24,027 shares in two transactions totaling $1.64 million at prices between $68.36 and $68.48.
  • Director Hannah Valantine exercised 8,671 options (intrinsic value $237,238.56) and sold all shares at $72 for $624,312 in proceeds.
  • Total open-market sales in the cluster: $2.27 million.
  • No open-market purchases or grants reported in the 7-day window.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access